ArticleJournal of Parkinson's disease2026
Transformation of Parkinson's care through SMART-PD (Self-Management, Remote monitoring and Timely review for Parkinson's Disease): Care pathway mapping with clinical experts.
Article in Journal of Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose of researchSMaRT-PD is a clinical decision support system (CDSS) for the home-based management and care of Parkinson's disease. It utilises remote monitoring and artificial intelligence to generate patient and clinician-facing outputs with self-management guidance, care recommendations and triggered follow-up appointments when needed. This study aimed to identify current care pathways for people with Parkinson's (PwP) and elicit healthcare professionals' perspectives on how the introduction of SMaRT-PD would affect current care.MethodsTwelve semi-structured interviews with health care professionals working in the management and care of people with Parkinson's in NHS secondary or tertiary settings informed care pathway analysis and thematic analysis.ResultsParticipants described a care pathway which largely aligned with guidelines. Limitations of the existing care pathway included lengthy time to diagnosis, inconsistent care, staff shortages and challenges of appointment length and frequency. Participants outlined the potential advantages of introducing a home-based pathway including patient empowerment and education, earlier identification of patients who require an in-person review, and efficient use of clinic time. Perceived challenges to implementation of a home-based pathway were clinical and administrative. One concern was that patients and staff would miss regular face-to-face contact. A key evidence requirement for the adoption of SMaRT-PD was identified as demonstrable patient, carer and staff satisfaction.ConclusionsParticipants were generally supportive of introducing a home-based pathway for people with Parkinson's, suggesting that SMaRT-PD could provide an opportunity to direct limited resources to where they are most needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.